Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: A phase I study

Lung Cancer

Volumn 53, Issue 2, 2006, Pages 183-188

  Klautke, Gunther ^a   Fähndrich, Sebastian ^a   Semrau, Sabine ^a   Büscher, Claudia ^a   Virchow, Christian ^a   Fietkau, Rainer ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Early radiotherapy; Irinotecan; Limited disease; Simultaneous chemoradiotherapy; Small cell lung cancer

Indexed keywords

CISPLATIN; IRINOTECAN; PREDNISOLONE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE EXACERBATION; DRUG RESPONSE; ESOPHAGITIS; FEMALE; HAIR LOSS; HUMAN; LEUKOPENIA; LUNG SMALL CELL CANCER; MALE; NEUROTOXICITY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SKULL IRRADIATION; THROMBOCYTOPENIA; VISUAL DISORDER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CARCINOMA, SMALL CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CRANIAL IRRADIATION; DISEASE PROGRESSION; DOSE FRACTIONATION; ESOPHAGITIS; FEASIBILITY STUDIES; FEMALE; HUMANS; LEUKOPENIA; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PNEUMONIA; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 33745587270     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.04.012     Document Type: Article

References (18)

1. Bunn Jr. P.A., Lichter A.S., Makuch R.W., Cohen M.H., Veach S.R., Matthews M.J., et al. Chemotherapy allone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. Ann Intern Med 106 5 (1987) 655-662
2. Pignon J.P., Arriagada R., Ihde D.C., Johnson D.H., Perry M.C., Souhami R.L., et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327 23 (1992) 1618-1624
3. Warde P., and Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10 6 (1992) 890-895
4. Fietkau R., and Sauer R. Die frühzeitige Radiotherapie im Rahmen der Radiochemotherapie des kleinzelligen Bronchialkarzinoms ist im Stadium "Limited Disease" der späten Bestrahlung überlegen. Strahlenther Onkol 178 11 (2002) 585-588
5. Huncharek M., and McGarry R. A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer. Oncologist 9 (2004) 665-672
6. Fried D.B., Morris D.E., Poole C., Rosenman J.G., Halle J.S., Detterbeck F.C., et al. Systemic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 22 23 (2004) 4837-4845
7. Sandler A.B. Current management of small cell lung cancer. Semin Oncol 24 4 (1997) 463-476
8. Turrisi III A.T., Kim K., Blum R., Sause W.T., Livingston R.B., Komaki R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340 4 (1999) 265-271
9. Sherman C.A., Rocha Lima C.M., and Turrisi A.T. Limited small-cell lung cancer: a potentially curable disease. Oncology 14 10 (2000) 1395-1403
10. Noda K., Nishiwaki Y., Kawahara M., Negoro S., Sugiura T., Yokoyama A., et al. Japan clinical oncology group: irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346 2 (2002) 85-91
11. Hanna N.H., Einhorn L., Sandler A., Langer C., Hariharan S., Ansari R., et al. Randomized, phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated, extensive-stage (ES) small cell lung cancer (SCLC). ASCO (2005) [Abstract 7004]
12. Pijls-Johannesma M.C., De Ruysscher D., Lambin P., Rutten I., and Vansteenkiste J.F. Early versus late chest radiotherapy foe limited stage small cell lung cancer. Cochrane Database Syst Rev 25 1 (2005)
13. Tada T., Minakuchi K., Koda M., Masuda N., Matsui K., Kawase I., et al. Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapy. Radiology 208 2 (1998) 511-515
14. Roof K.S., Fidias P., Lynch T.J., Ancukiewicz M., and Choi N.C. Radiation dose escalation in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 57 3 (2003) 701-708
15. Choi N.C., Herndon II J.E., Rosenman J., Carey R.W., Chung C.T., Bernard S., et al. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 16 11 (1998) 3528-3536
16. Kudoh S., Fujiwara Y., Takada Y., Yamamoto H., Kinoshita A., Ariyoshi Y., et al. Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan lung cancer group. J Clin Oncol 16 3 (1998) 1068-1074
17. Oka M., Fukuda M., Kuba M., Ichiki M., Rikimaru T., Soda H., et al. Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer. Eur J Cancer 38 15 (2002) 1998-2004
18. Takeda K., Negoro S., Kudoh S., Okishio K., Masuda N., Takada M., et al. Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer. Br J Cancer 79 9-10 (1999) 1462-1467